Under the terms of the collaboration agreement, PolyTherics will explore the biological effects on proteins of Biocompatibles’s proprietary phosphorylcholine drug delivery technology. This new study builds on the
The purchase price consisted of cash and debt. Lumar Diagnostic Imaging will operate as a wholly owned subsidiary of Bederra under the new name of Lumar Imaging. Graham
The randomized, double-blind, placebo-controlled study measured whether supplementation with chromium picolinate for a 12-week period might affect brain activation under working memory task demands in 13 older adults
The round was led by Edmond de Rothschild Investment Partners, with participation from Biogen Idec New Ventures and Fortis Private Equity, as well as existing series B investors
The joint-venture company, StemCyte India Therapeutics, will provide stem cell therapies derived from umbilical cord blood to treat patients with certain malignant blood disorders, including leukemia, lymphoma, myeloma
The pending patent covers systemic use of the drug, PH-12, for photodynamic treatment of cancer, skin diseases, and other tissue disorders using visible light activation. Craig Dees, CEO
The company said that in addition to alomost 35 years of experience serving a global customer base, BioVectra’s FDA-approved cGMP facility was a key factor in awarding the
This round brings the total amount raised since the company’s inception to date to E27 million. The financing strengthens the company’s balance sheet and allows the progression of
Analysis of the pharmacokinetic data from this study and other bevirimat clinical studies has revealed the bevirimat target blood levels, or threshold, above which patients are likely to
Researchers at Brown Cancer Center have discovered that 3PO inhibits a key enzyme, PFKFB3, which suppresses both sugar metabolism and cell proliferation among cancer cells. In addition, 3PO
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.